Overview

A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules

Status:
RECRUITING

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

The main objective of which is to evaluate the relative bioavailability and PK characteristics of new and old ABSK-011 capsules in a single oral dose

Phase:

PHASE1

Details

Lead Sponsor:

Abbisko Therapeutics Co, Ltd